Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)

38.08
BATS BZX Real-Time Price
As of 2:11pm ET
 +0.09 / +0.24%
Today’s Change
19.06
Today|||52-Week Range
40.14
+72.86%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Dicerna Pharmaceuticals Inc have a median target of 38.00, with a high estimate of 38.25 and a low estimate of 26.00. The median estimate represents a -0.21% decrease from the last price of 38.08.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Hold stock in Dicerna Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.54
Sales
$41.3M
Reporting Date
Mar 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -146.34%
 
 
 
 
 
 
Growthannually -10.82%
 
 
 
 
 
 

Sales

Growthquarterly -34.46%
 
 
 
 
 
 
Growthannually 17.42%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.